Upload
sheila-lamb
View
213
Download
0
Tags:
Embed Size (px)
Citation preview
Destruction of Industrial Biofilms
Grant Burgess
School of Marine science and Technology, Newcastle University
Overview
What are biofilms and why are they a problem
Structure of biofilmsA 3.5 billion year old problemDiscovery and characterisation of a
biofilm dispersing compoundApplicationsConclusions
What are biofilms ?
Biofilms are sticky layers of slime that build up on surfaces exposed to non sterile liquids
Why are they a problem
Ship fouling Increased drag and fuel costs
Corrosion Microbially influenced corrosion
Food processing plants Costs of cleaning
Breweries Wastewater treatment Laundry cleaning
A 3.5 billion year old problem Bacteria evolved about 3.5 billion
years ago They have been competing with
each other all this time Biofilms have evolved to provide a
protective layer, for example against antibiotics
Also To enable greater control of their
environment, (pH, nutrients) To allow the development of complex
communities which can repel outsiders
A marine discovery
Studied seaweed surfaces in Scotland Many bacteria live on these surfaces Many strains of bacteria can attack and dissolve
the biofilms of their competitors We isolated a compound that could dissolve
biofilms Working with Mike Hall in the School of
Chemistry we identified the compound as a DNA degrading nuclease, NucB from the bacterium Bacillus licheniformis
NUCB Purification
NUCB was purified by a combination of ammonium sulphate precipitation and chromatography on a Q Sepharose column.
The purity of the protein was analysed by SDS PAGE using a 20% acrylamide separating gel (see below) using increasing loadings (3 to 12l) of the final pool of protein.
The identity of the protein was confirmed by mass spectrometry (MALDI PMF).
Approximately 12.5 mg of NUCB at greater than 95% purity was recovered from 800mls of starting culture supernatant.
3 6 9 12l
Solution Mr determination of NUCB by size exclusion chromatography.
Buffer: 50mM KPO4 pH 7.2, 1mM DTT, 150mM NaCl.
Samples and concentration: NUCB 0.25mg ml-1.
200L of NUCB chromatographed on a Superdex 200 HR10/30 FPLC column at a flow rate of 0.5m min-1, collecting 0.5ml fractions.
The column was calibrated with Mr markers consisting of blue dextran, apoferritin, alcohol dehydrogenase, BSA, carbonic anhydrase and cytochrome C.
NUCB (12-kda) eluted at the same position as cytochrome C (12.4kda).
NUCB is monomeric.
Analysis of the far-UV spectrum of NucB using the Dicroweb server.
The CD spectrum of NUCB was analysed using Dicroweb.
This database contains the secondary structure content of thousands of proteins known from their crystal structures and also the CD spectra of these proteins.
The programme looks for the best fit between the far UV CD spectrum of the protein under investigation and those in the database
NUCB has a mixed secondary structure content that is highly similar to a protein that has been analysed by X-ray crystallography
Towards commercial application
UK patent granted 2011 PCT filed 2011 Currently working with several multinational
companies that have expressed interest in this anti-biofilm technology
In addition to industrial biofilm, many examples of biofilms causing medical problems
Toxicity data also confirm safety Established protocols for scale up and production
Conclusions
Understanding of science behind the problems can lead to new biotechnology products
Multi-disciplinary team essential Requires good industry academia dialogue
and mutual understanding Work with your local Universities to address,
understand and solve your problems Develop a culture of Industry – University team
work, not just one off projects
Acknowledgements
Dr Nick Jakubovics
Lecturer in Oral Microbiology
Dr Reindert Nijland
Utrecht Medical Centre
Dr Mike Hall
Lecturer in Organic Chemistry
Dr Sam Neill
Commercialisation Team
Protein purification and characterisation:Alastair Hawkins, Heather Lamb and Paul Thompson
Ms Nithya RajarajanPhD studentChemical Engineering